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Abstract

Introduction

This review covers the applications of electron
microscopic techniques to the characterization and evaluation of drug delivery systems. Various electron microscopic (EM) related techniques such as transmission
electron microscopy, scanning electron microscopy
(SEM), SEM with energy dispersive X-ray microanalysis, and freeze-fracture electron microscopy are extensively used for this purpose. Microcapsules, microspheres, nanocapsules, liposomes , polymeric carriers
and other drug delivery systems are characterized using
EM related techniques for their surface topography, size
and shape analysis, biodegradation, in vitro - in vivo
evaluation and drug excipient interactions and characterization. Electron microscopy methods are very useful in
understanding the mechanism of drug carrier formation,
drug release in in vitro - in vivo situations, and drug
carrier - body fluid interactions . EM techniques have
also been used to study ultra-structural disposition of
drug carriers in body compartments.

Drug use must be as old as the human race. The
administration of drugs to the human body has been a
constant challenge for the scientists working in health
related fields. The two major approaches for the administration of drugs are: a). Conventional dosage forms ,
for examples: tablets, capsules, emulsions, solutions,
etc.; and b). Controlled drug delivery systems, for
examples : microcapsules, nanocapsules, polymeric carriers, liposomes, etc.
Both approaches have two common ingredients:
the active drug and the excipients being used to formu late the dosage. The broad differences between these
two are the mechanism and site of release. These factors have played an important role in the advantageous
applications of drug delivery systems over conventional
dosage forms.
In recent years, considerable attention has been
targeted on the development of new drug delivery systems. A few of the important reasons for this extensive
researcb on drug delivery systems by the pharmaceutical
industry, academia, and related health scientists are:
a) The high cost of new drug development has
initiated research to find suitable, efficient ways of delivering existing drugs with a higher therapeutic efficiency .
b) The repatentability of the drug delivery systems for the existing drugs.
c) New systems of delivery are needed for the
transport of novel genetically engineered pharmaceuticals, i.e., peptides and proteins, to their sites of action
without incurring significant adverse immunogenical response or biological inactivation.
d) The targeting of very potent drugs, especially
in cancer therapy, to avoid excessive side effects.
e) The therapeutic efficacy and safety of the
drugs can be improved by administering them as controlled release or polymeric delivery systems for transdermal administration.
f) Finally drug delivery systems can utilize electronic and computer technology to deliver the drug at a
particular target in the body; for example, pulsed and/or
self regulated drug delivery systems.
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Table 1. EM related techniques used in characterizing and evaluating drug delivery systems (DDS).

EM Technique
Scanning Electron
Microscopy

Drug Delivery System
Microspheres

References

Miscellaneous

6, 8, 10, 12, 16, 17, 21, 27, 36, 38, 49, 50, 55, 57, 66, 73, 90,
95, 110, 113, 115, 116, 137, 138, 141, 149, 156, 157, 161,
162, 165' 166, 172, 173.
8, 15, 20, 23, 48, 63, 76, 77, 81, 82, 83, 93, 96, 102, 105,
107, 109, 114, 119, 126, 134, 135, 139, 146, 147, 150, 151,
152, 160, 170, 179, 181.
28, 29, 68, 92, 98, 103, 112, 121, 180.
45, 94, 118, 124, 132, 155, 176, 177.
37, 46, 47, 91, 183.
9, 11, 24, 26, 61, 69, 75, 86, 100, 120, 125, 130, 131, 133,
140, 159, 167' 182.
19, 25, 34, 41, 52, 67, 78, 79, 80, 99.

Transmission Electron
Microscopy

Li po so mes
Nanocapsules
Polymeric
Microcapsules
Implants

2, 4, 132.
3, 5, 13, 14, 111.
11, 140.
42, 77, 136, 142, 148, 174.
72, 178.

SEM with X-Ray
Microanalysis

Polymeric
Matrix Carrier
Micro spheres

61, 75, 101, 130.
56, 145.
137.

Freeze-fracture EM

Liposomes

33, 44, 117, 122, 144, 155.

Microcapsules

Matrix Tablets
Li po so mes
Nanocapsules
Polymeric Films

Electron microscopic (EM) techniques have been
used extensively in characterizing and/or evaluating various drug delivery systems. The purpose of the present
paper is to review various EM techniques used for these
purposes as well as to bring together different areas related to drug delivery systems in which EM techniques
have been used to characterize and/or evaluate the systems (Table 1). EM techniques have been used to characterize polymeric implantable delivery systems and
some excipients used in the formulation of drug delivery
systems in our laboratories. Application of scanning
electron microscopy related techniques in drug delivery
system formulation, development and evaluation can be
classified in three phases: a) preformulation (Table 2);
b) formulation and in vitro characterization (Table 3); c)
in vivo evaluation and effectiveness (Table 4).
Various EM related techniques used for this purpose are given in Table 1, which includes scanning electron microscopy (SEM), transmission electron microscopy (TEM), SEM energy dispersive X-ray microanalysis, and freeze-fracture electron microscopy.

therapeutic efficacy of the drug delivery systems [135].
The drug incorporation, distribution, and release from
the drug delivery systems, such as, controlled release
matrix tablets [28, 29, 71], microcapsules [6, 102, 105],
microspheres [12 , 115, 166], polymeric carriers [9, 24,
159], are affected by the size and shape of drug-excipient particles. EM techniques have been used to study
the surface properties of drugs particles [35, 37] and excipients [129, 140, 163] and to relate them to their usefulness in delivery systems.
In our laboratories, maltodextrins (D-glucose
saccharide polymers) for use as excipients in drug
delivery formulations, have been characterized. Maltodextrins are non-sweet, nutritive saccharide polymers
that consist of D-glucose units linked primarily by alpha
1-4 bonds and have a dextrose equivalent (DE) value less
than 20. We evaluated maltodextrins (normal, agglomerated, and superagglomerated with different DE
values), as excipients in matrix based delivery systems
[123]. The bulk density of various maltodextrins M-040
(DE = 4), M-100 (DE= 10), M-150 (DE= 15), M-700
(Superagglomerated M-100) was measured by tapping 10
grams of the powder more than 100 times or until there
was no change in volume. Flow properties were determined by the cone and funnel method and the angle of
repose calculated (Table 5). Surface properties of
maltodextrin derivatives were studied using SEM (Fig.
1 for M-040 and Fig. 2 for M-150). It was observed

Applications of EM in preformulation stage
Shape, surface, and particle size distribution of drug
and excipient particles
The shape, size, and surface characteristics of the
drugs as well as the excipients significantly affect the
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Table 2. SEM applications in preformulation stage of drug delivery systems.
Parameter

References

Shape, size and surface characterization of
drug and excipients

35, 38, 55 , 62, 73 , 84, 88, 89, 94, 97, 98, 102, 107, 108,
114-116, 128, 131, 134, 139, 143, 156, 163, 172, 181.

Particle size distribution

23, 36, 49, 53, 90, 93, 102, 105, 151.

Effect of Processing and formulation variables
on drug delivery system characterization

10, 12, 14, 16, 17, 27, 30, 31, 32, 46, 48, 53, 59, 61, 63,
81, 84 , 97, 103, 116, 124, 143, 156, 179.

Mechanism of compression and deformation of particles

40, 51, 54, 129.

Crystal structure and formation studies

51, 54, 129.

Granulation processing effect on particle surface

35, 38, 39 , 54 .

Polymeric film studies

24, 56, 69, 103, 121, 140, 145, 174.

Drug - Excipient Interaction

39, 40.

Empty microcapsule/nanocapsule studies

13, 17, 53, 58, 115.

Mechanism oriented studies

26, 29, 63 .

Table 3. SEM applications in formulation and in vitro evaluation of drug delivery systems .
Parameter

Reference

Effect of drug loading on surface morphology
of microspheres/nanocapsules

16, 20, 25, 53, 63, 81, 84, 90, 93, 97, 104,
105, 114, 115, 116, 122, 136, 139, 166, 173.

Drug distribution, morphology, permeability,

in vitro release in polymeric carriers

56, 59, 61, 81, 84, 98, 100, 103, 112, 115,
117, 119, 130, 132, 169, 172 .

Matrix tablet surface morphology and changes during in vitro release

28, 29, 68, 121, 180, 182.

Physical structure of dry absorbed emulsions

19, 79, 80.

Liposomes: collagen gel matrix surface characterization

99, 176.

Calcification of carriers/implant studies

72, 75 , 99, 101, 158, 164, 175.

Mechanism of drug carrier formation,
degradation and drug release mechanisms

15, 19, 28, 43, 53, 85, 97, 112, 113, 115,
127' 130, 140, 167' 171.

Table 4. SEM applications in characterizing and evaluating drug delivery systems in vivo.
Parameter

References

Effect of in vivo conditions on size, shape and surface of
microcapsules and other drug delivery systems

42, 60, 65, 70, 71, 86, 87, 100, 133,
144, 157, 161, 162, 168.

Ultra structural disposition/distribution

42, 44, 47, 66, 74, 86, 155.

Pathological effects of drugs released

7, 45, 66, 71, 86, 142, 178.

Blood-plasma compatibility of drug carriers

1, 3, 11, 125, 168, 178.

Mechanism of drug penetration: corneal uptake, lymphatic uptake, etc.

64, 178, 183.

Bioerosion of drug delivery systems in body

22, 43, 115, 157, 161, 170.

Mechanism of drug release

65, 86.
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Table 5. Micromeritic properties of maltodextrins
Maltodextrin
derivative

DE
value

Bulk
density* g/ cc

Angle of
repose *

M-040
M-100
M-150
M-700

4
10
15
10

0.33
0.42
0.48
0.15

63°
39°
380
36°

Gonda [129] showed that significant changes occurred in
morphological properties of bagasse based microcrystalline cellulose (MCC) during compression. It was observed that significant differences in the particle
morphology of MCC from different sources affected the
mean hardness, friability loss, and disintegration time of
tablets prepared from these excipients.

Drug crystal formation and structure
Application of SEM in the preformulation stage of
drug delivery systems is reported by Otsuka and
Kaneniwa [128]. They studied the polymorphic transformation of chloramphenicol palmitate during the grinding
process and have used SEM to characterize and identify
the polymorphs and transformations in particle surface
topography during processing. Another similar study
has also reported the effect of compression on crystal
structure [51]. A model has been developed to predict
the uniaxial compaction behavior of compacts using the
hardness and elastic moduli of brittle crystals determined
by the Vickers microindentation test. SEM has been
used to characterize the crystals and compacts during
and after compression of acetaminophen, sucrose, and
adipic acids. Electron micrographs of a fractured sucrose compact showed substantial crushing at the asperities. The SEM observations supported the assumption
that the fragments arising from crushing bear no load at
lower relative densities [51].

*Average of three readings.

that M-150 with DE value of 15 had many more elongated particles than M-040 with DE value 4. These exhibited different micromeritic and compressional properties when used as a directly compressible excipient in
tablets [123]. A detailed report of the morphological
characterization of maltodextrins using SEM and the correlation with micromeritic properties is being published
in this issue of Cells and Materials [153].

Effect of processing techniques on drug or excipient
particles
SEM has been used widely in studying particle
properties and changes in surface characteristics during
various processes like spheronization [88, 89], partial
dissolution, swelling due to aqueous contacts, spraydrying [90], granulation, and agglomeration [35, 38, 39,
54]. SEM is a very effective tool in studying surfaces.
In our studies of maltodextrins (Figs. 3 and 4), the agglomeration process significantly increased the particle
size and thus affected the bulk densities of these products' (Table 5). The low bulk density of M-700 can be
attributed to the highly fluffy nature of these super agglomerated products. Figs. 3 and 4 show the micrographs of M-700 powders. It is observed that the agglomeration process has led to the formation of bigger
particles with large void volumes in the particles, thereby decreasing the bulk density. The spherical particles
are seen to attach to each other at one point. Every particle has an empty hollow space. The agglomeration
process has increased the surface area enormously thus
increasing the area of contact with other components
such as air, moisture, and body fluids (when incorporated in drug delivery systems).

Polymeric film casting and film studies
SEM and TEM have been used to characterize
polymeric films and castings of polymeric strips as drug
carriers [18]. SEM has been used to give direct evidence of the morphology differences among ethylcellulose cast films with and without a drug [9]. Depending
on the formulation and casting procedures, the film surfaces have been observed to be either smooth or rough
with engulfed air pockets. TEM has been used in this
study to reveal the influence of glass on the texture of
samples [11]. It is reported that randomly distributed
crystalline zones formed at the air side of the films
which might account for the extreme heterogeneity of the
films. Micrographs of the cross-section of films clearly
indicated the heterogenous internal structure of the polymer. Hsiue et al. [72] in their studies on the preparation
and properties of poly(2-hydroxyethyl methacrylate)
(PHEMA) grafted styrene-butadiene-styrene triblock copolymer (SBS) used SEM to characterize the surface
morphology of copolymers with different degrees of
grafting. They observed that the morphology of the surface of the graft copolymer changed with the degree of
grafting [72]. The vertical sections of the membrane
showed a lower SBS layer and an upper PHEMA layer
[11]. Bakker et al. [l l] studied the biocompatibility of
two silicone rubber polymers and a polyurethane polymer in vitro. Using SEM/TEM and quantitative analysis
the epithelial morphology showed that polyurethanes and
polyether-polyester copolymer have better biocompatibility than that of silastic rubber polymers [72].

The mechanism of compression and deformation of
powders
SEM techniques have been employed to study the
mechanical properties of drug/excipient compacts [128],
as well as the effect of compression on drug/excipient
surface properties. The deformation of powders during
compression and breaking has helped in understanding
the mechanism of compression as well as the constitutive
properties of matrix tablets which are one of the most
widely used delivery systems for controlled release of
drugs [39, 51, 54]. A study by Padmadisastra and
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Figures 1-4. Scanning electron micrographs of maltodextrin M-040 (Fig. 1); M-150 (Fig. 2); and M-700 (Fig. 3 and
4) powders. In Figure 4, one of the agglomerated particle is viewed showing spherical hollow particles agglomerated
together. Bars = 100 µm (Figs. 1, 3 and 4) and 10 f'm (Fig. 2).
Drug excipient interaction and characterization
The interaction between drugs and excipients
which are either inert additives, sustained release polymeric matrices, or films have been extensively studied
by SEM [38, 39]. Our investigation of maltodextrins
has shown that the agglomeration affected the excipient
properties. The micrographs for M-040 (Fig. 1), M-150
(Fig. 2), and M-700 (Fig 4) show the effects of agglomeration and superagglomeration on the particle shape and
surface of maltodextrin. The M-700 powder had a low
bulk density (Table 5) which correlated with hollow
structures containing air pockets in the maltodextrin (see
Fig. 3). A study of the drug loading mechanism in
cross-linked polymers has been reported by Carli and
Garbassi [34] using X-ray photoelectron spectroscopy.
SEM also has been used to examine the surface characteristics of drug excipient mixtures [39]. Figure 5
shows a micrograph of griseofulvin-crospovidone matrix

system used as a drug carrier [34].
Empty microcapsule and nanocapsule studies
SEM has been employed in studying the development of empty microcapsule and nanocapsule formulations using several polymers [ 13, 17]. Benita et al. [17]
reported the preparation of carnauba wax microspheres
with and without a drug (5-Fluorouracil) to show how
various process parameters affect the preparation and
properties of carnauba wax: 5-fluorouracil microspheres
[17]. A similar study has been reported for nanocapsules [13]. The surface characterization of empty carriers has been performed SEM and TEM in both studies
[13, 17]. These studies have been aimed at exploring
the effects of various formulation and processing variables on surface, shape and size of microcapsules [53, 58]
and microspheres [115]. TEM was found to be more
useful for characterizing nanocapsule formulations [3, 5,
13, 15, 111].
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SEM Applications in Formulation and In Vitro
Characterization of Drug Delivery Systems

Emulsions
Another interesting application of SEM has been
in characterizing emulsions. Oral sustained release of
drugs has been reported to be obtained by adsorbing the
emulsion on silica. SEM was used to locate the drug
crystals engulfed in the oil droplet adsorbed on silica
particles [19]. SEM was also used in characterizing
emulsions carrying microcapsules [80]. Microspheres
containing multiple emulsions and coated emulsion particles with polysaccharides have been characterized using
SEM. In a study of the coating of surfaces of oil in
water (o/w) emulsions using polysaccharides bearing a
cholesterol moiety, Iwamoto et al. [79] successfully used
SEM to determine the shape, size, and surface properties
of the emulsion systems (Fig. 8).
Formulation, surface characterization of liposomes
TEM [2, 5, 132] and freeze fracture electron microscopy [33, 44, 117] have been used extensively to
characterize surface morphology of liposome-drug delivery systems [122]. TEM was used to study the bilayer
structure of polymerized liposomes. TEM helped in revealing that the polymerization reaction (between phosphatidyl choline vesicles stabilized by polycholesteryl
methacrylate and carboxy methyl chitosan) increased the
vesicle membrane stability [2]. Freeze fracture electron
microscopy was employed in investigations of surface
properties as well as drug incorporation studies [ 145,
155]. Metha et al. [118] evaluated liposom·e s containing
amphotericin B for toxic and antifungal activities. Figure 9 shows a micrograph of liposomes.
Calcification of drug carriers
Calcification is a normal physiological phenomenon. Several drug carriers, such as, polyurethane and
hydro gels [75, 158] undergo calcification. Furthermore,
bioprostheses based on either natural tissues or sypthetic
polymers also undergo calcification [69, 99, 101]. SEM
has been used to characterize the surface changes in the
heart valve bioprosthesis due to the calcification processes when implanted in rats [146, 175].
Mechanism of drug carrier formation, degradation
and drug release mechanism from biodegradable polymeric carriers
SEM has been used in characterizing the formation of microcapsules and microspheres by such techniques as polycondensation [8], coacervation [23, 48,
107], or solvent evaporation [15, 106, 157]. The effect
of processing and formulation variables on surface topography was studied by SEM [20, 81, 82]. Microcapsule interactions with water or body fluids in vitro, and
changes in their properties have been critically observed
with the SEM [63, 76]. In the case of biodegradable
polymeric carriers, the biodegradation during contact
with body fluids was observed by SEM [53]. This
helped in understanding the kinetics and mechanisms of
biodegradation as well as of drug release from these
carriers [85, 112, 113, 116]. TEM is reported to be
useful in studying ultrastructural characterization of

Effect of drug loading
The objectives of the formulator in designing drug
delivery systems is to explore the possibility of administering the desired amount of drug to the body. The desired amount varied from drug to drug. Hence, incorporation of different amounts of drugs (drug loading) in
drug carriers has been extensively studied in drug delivery systems. SEM and TEM have been employed in
studying drug loading effects on microcapsules [106,
107], microspheres [16, 110], nanocapsules [16, 46, 93],
and polymeric film carriers [130, 131]. It was observed
that the surface characteristics were significantly
changed by the degree of drug loading. In one of our
studies [12, 16] we have incorporated nifedipine in polymethacrylate microspheres with drug loadings from 5 to
31 % and found that the smooth surface present at 5 %
drug loading was gradually shifted to a very rough surface at 31 % incorporation which affected the stability
and in vitro drug release from these microspheres. In a
study by Kawashima et al. [90] controlled release microspheres have been prepared by a quasi emulsion solvent
diffusion method for Ibuprofen. SEM has been used to
study the surface topography of various microsphere formulations depicting the differences in surface topography with different polymers [90].
Drug distribution, morphology, permeability, and in
vitro release in polymeric film carriers (matrices)
Polymeric carriers are widely used, especially in
the field of cardiovascular and contraceptive drug delivery systems. SEM is used for the study of drug distribution in the polymeric matrix, morphological characterization of matrices [61], permeability studies [11, 26,
133], drug loading effects [100, 101], and surface characterization during in vitro drug release studies [130,
131]. We have used SEM in investigating drug distribution and surface morphology during release studies for
verapamil polymeric carriers (154). Figures 6 and 7
show the surface of films during pre- and post-release
studies. It was observed that the drug had been uniformly distributed in the polymeric matrix. During the
in vitro release process the particles swell and gradually
leave the matrix forming holes and channels in the polymeric matrix surface (Fig. 7). A similar mechanism of
release has also been observed in our other studies in
which Fe3 +, Al3 +, or levamisole have been incorporated
in polymeric carriers (polyurethane or silastic rubber
polymers) for the prevention of heart valve calcification
[130, 131].
Sustained release matrix tablets
SEM has been used for characterizing surface
properties of sustained release matrix tablets as well as
studying the changes which occur in the tablet surface
during release [71, 98]. Surface properties and uniformity of film coating in coated tablets used for sustaining
the drug release have been also characterized [28, 29].
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Figure 5. Scanning electron micrograph of griseofulvin-crospovidone carrier system. (a) 1:5 w/w, bar= 10 µm; (b)
1: 10 w/w, bar = 4 µm (from reference 34 with permission from the Amer. Pharmaceutical Association).
Figure 6. Scanning electron micrograph of sustained release polymeric carriers (films) of verapamil, showing uniform
distribution of drug in polymer film. Bar = 10 µm.
Figure 7. Scanning electron micrograph of sustained release polymeric carrier (films) of verapamil during in vitro release studies after 3 weeks showing particle swelling and hole formation due to loss of drug particles during in vitro
release studies. Bar = 10 µm.
Figure 8. Scanning electron micrographs of (a) conventional and (b) CHE:200 = 1:8 coated oil droplets in o/w emulsions on a filter paper. The CHM:200 coated droplets were prepared from 1 ml of conventional o/w lecithin emulsions
and 7.2 mg CHM:200 = 1 :8; bars = 2 µm (from ref. 79 with permission from the Amer. Pharmaceutical Association) .
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microcapsules and nanocapsules. The semipermeable
membranes in microcapsules have been characterized by
TEM [14, 41, 77, 174]. Another study reported the application of SEM in studying the internal structure of
polyamide microcapsules and the effect of irradiation on
microcapsule surface properties [ 114]. Figures 10 and
11 show the typical nanocapsule formulations viewed by
TEM [4].

useful in delivery system where accumulation of the drug
carrier in cancer or body tissues releases the drug over
sustained periods of time. The tissues have been characterized using SEM for the pathological effects due to
constantly released drug over longer periods of time [68,
86]. The effects of drugs from a delivery system on cell
structure have also been studied [144, 178], as part of in
vivo evaluation of the carriers.
Blood-plasma compatibility of drug carrier
Delivery systems such as nanocapsules and liposomes can be intravenously injected and can come in
contact with blood-plasma components immediately after
the injection. Their compatibility with circulating blood
and its contents becomes of prime importance. Absolom
et al. [l] studied the role that substrate surface properties play in influencing the extent of endothelialization
of polymer surfaces during in vivo implantation and the
interaction of body components with polymer carriers.
Published micrographs show different degrees of endothelialization for different polymer surfaces when exposed to blood in vitro. Other similar reports have
shown applications of EM techniques in studying the
biocompatibility between drug carriers and blood, interactions between them, and changes occurring during the
contact time [11, 126, 168, 178].
Mechanism of drug penetration from drug delivery
system
Application of SEM is reported in understanding
the mechanism of drug penetration in the cornea through
ocular drug delivery systems [64]. Zimmer et al. [180],
during their studies on the transport of PBCA nanoparticles in ocular tissues, showed that the PBCA nanoparticles penetration in eye tissue is limited to the precorneal
area only.
Penetration through tight junctions or
through whole corneal tissue did not occur. They also
studied the corneal sections by laser scanning confocal
microscopy and suggested an uptake mechanism by
phagocytosis [183].
SEM is also used to understand the mechanism of
drug uptake through lymphatic systems. Williams et al.
· [ 178] have reviewed the electron microscopy of endothelial cell-biopolymeric interaction.
Bioerosion of drug delivery systems in vivo
The drug delivery systems based on biodegradable
polymers such as pol yanh ydrides [ 113, 115, 116] or
polycaprolactone [14] have been studied using SEM and
the bioerosion of the carriers has been monitored [ 167].
SEM has been useful in understanding the mechanism of
surface erosion of microspheres [42~ 116]. Brem et al.
(22] studied the brain biocompatibility of a biodegradable controlled release polymer consisting of an anhydride copolymer of fatty acid dimer and sebacic acid.
The biodegradable carriers were implanted in the brain.
The localized reaction evoked due to polymer implantation and bioerosion of drug carrier was monitored using
EM techniques. The study showed an important application of these polymers in delivering a water soluble drug
by bypassing the blood-brain barrier.

SEM Applications in Characterizing and
Evaluating Drug Delivery Systems In Vivo
Effect of in vivo conditions on size, shape, and surface
of drug delivery systems
In vivo interaction of various drug delivery systems, such as microcapsules [41, 144], micro spheres
[65, 157, 162], liposomes [44, 45], and polymeric carriers, have been studied extensively using EM and other
related techniques [70, 71, 86, 100, 133]. Biodegradation [46, 157], phagocytosis [161], uptake by body compartments such as liver, Kupffer cells, etc. has been observed [45, 74]. Clayton et al. [41] studied the effect of
capsule composition on the biocompatibility of alginatepoly-1-lysine capsules. Empty capsules from high mannuronic acid alginate have been prepared and coated with
poly-I-lysine alone, poly-I-lysine and guluronic acid and
poly-I-lysine and high mannuronic acid alginate. The
capsules have been placed in renal subcapsular space or
the peritoneal cavity and retrieved after 3 weeks for histological and electron microscopical study to evaluate interaction of body cells and drug carriers as well as the
fate of drug carriers in in vivo conditions. The infiltrating cells in the capsule surface have been characterized
to be mostly fibroblasts and macrophages. Similar studies have also been reported [157, 170]. It is also reported by Krause et al. [92] that liposomes formed aggregates (when administered intravenously) during circulation thus affecting the drug release.
Ultrastructural disposition and distribution of carrier
particles
The uptake of the carrier particles in various body
compartments [8, 45, 66], their distribution throughout
the body [44, 46, 74], the accumulation [75], and ultrastructural disposition has been studied using SEM. The
microcapsules and nanocapsules administered orally [74]
or by a parenteral route [157] have been monitored to
study their distribution and accumulation in the body .
SEM was found to be helpful in localizing these carriers
in various tissues in the body [161]. Illum et al. [74]
used SEM to study the distribution of model carrier particles (polystyrene microspheres) in the reticuloendothelial system. Figures 12 and 13 show the accumulation of
these microspheres in Kupffer cells [74].
Pathological effects of drugs
Several research papers have reported the application of EM techniques to the study of pathological effects of drugs released through drug delivery systems at
the target site [8, 45, 66]. This has been an especially
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Figure 10. Transmission electron micrograph of PLA
nanocapsules prepared according to standard conditions
by interfacial deposition of poly (D,L-lactide) polymer.
From reference 5 with permission from the American
Pharmaceutical Association.
Figure 11. Transmission electron micrograph of PLA
nanocapsules showing the presence of large multilamellar phospholipid vesicles . From reference 5 with permission from the American Pharmaceutical Association.
Figure 12. Electron micrograph showing Kupffer cells
situated between a sinusoid(s) and liver cells (L)
following administration of 10 13 polystyrene microspheres of 359 nm diameter. The Kupffer cells are filled with the microspheres. From reference 74 with permission from the American Pharmaceutical Association.
Bar= 1 µm.

100nm

----.

Figure 9. Electron microscopic profiles of amphotericin
B containing DPL vesicles. The size distribution of
polymerized DPL vesicles is quite heterogenous as is
typical for multilamellar vesicles. Large multilayered
vesicles in the 2-4 µm size range are visible along with
an abundant background of smaller vesicles. From reference 118 with permission from the American Pharmaceutical Association .

Figure 13. Electron micrograph showing groups of particles (P) within a liver cells (L) 8 days following administration of 10 13 polystyrene microspheres of 359 nm
diameter. c: bile canaliculus; m: mitochondrion; g:
glycogen; r: rough endoplasmic reticulum. From reference 74 with permission from the American Pharmaceutical Association. Bar = 1 µm .
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Mechanism of drug release, absorption, phagocytosis
and elimination in drug delivery systems
SEM techniques have been used to study the in
vitro - in vivo interaction of drug delivery systems such
as microspheres [16, 65], microcapsules [20, 41], or
nanocapsules [3 , 4] undergoing phagocytosis by macrophages [13]. The surface morphology of polymeric
films in vi vo after implantation has been studied by SEM
and it is reported that the drug particles underwent
swelling and were released from the surface forming
holes and in time, channels [53] . Release mechanisms
of biodegradable [81 , 84] or non-biodegradable microspheres [12, 14] have been reported from a study of the
surface topography during in vivo observations. Povey
et al. [ 135] studied the delivery of chemical carcinogens
with magnetic polyethyleneimine microcapsules by in
vivo trapping of electrophiles from N-methyl-N-nitrosourea and recovery from feces. The mean diameter of
administered and recovered microcapsules has been reported to be different. The micrographs of these recovered microcapsules showed the adsorption of particles of
an unknown character as well as surface changes follow ing the in vivo exposure [135].
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and process optimization. Drug Dev. Ind. Pharm. 16:
2057-2075.
13. Barratt GM, Yu WP, Fessi H, Devissaguet
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(1989) Delivery of MDP-L-alanyl-cholesterol to macrophages: comparison of liposomes and nanocapsules.
Cancer Journal 2: 439-443.
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JP (1992) Levamisole-PLA biodegradable nanocapsules .
Proceed. Intern. Symp. Controlled Release Bioactive
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IL. 19 (abstract).
15. Benita S, Donbrow M (1982) Dissolution rate
control of the release kinetics of water-soluble compounds from ethyl cellulose film-type microcapsules.
Int. J. Pharm. 12: 251-264.
16. Benita S, Barkai A, Pathak YV (1990) Effect
of drug loading extent on the in vitro release kinetic
behaviour of nifedipine from polyacrylate microspheres.
J. Control. Rel. 12 : 213-222.
17. Benita S, Zouai 0 , Benoit JP (1986) 5-Fluorouracil : Carnauba wax microspheres for chemoembolization: An in vitro evaluation . J. Pharm. Sci. 75: 847-851.
18. Benita S, Dor P, Aronhime M, Marom G

Conclusions
Electron Microscopy techniques have been used
extensively in characterizing and evaluating drug delivery systems . Due to the complex nature and microstructure of most of these delivery systems , EM is very useful in understanding surface topography . It is used to
study the effects of formulation and processing variables
on the properties of drug delivery systems. It is also a
very useful tool in the understanding of the mechanisms
of a drug delivery system formation release, ultrastructural disposition and distribution , in vivo uptake and
bioerosion. In the last few years, EM has achieved an
indispensable status in drug delivery systems research ,
development, characterization and evaluation.
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Discussion with Reviewers

S.K. Williams: What drug delivery systems currently
appear to be the most promising for the delivery of
genetically engineered pharmaceuticals, particularly
peptides and proteins?
Authors: Currently, several drug delivery systems are
being evaluated as carriers for proteins and peptides.
Liposomes, stealth and immunoliposomes, nanocapsules,
submicronized emulsions and polymeric carriers show
promising applications for delivering specific proteins
and peptides. None of them can be used generically for
delivering proteins and peptides. Each has advantages
and disadvantages when considered as carriers especially
for proteins and peptides.
M. Foldvari: Would you comment on the quantitative
aspects of EM for pharmaceutical characterization purposes?
Authors: EM techniques can often be used to characterize particle size of pharmaceutical systems, especially
when the dispersed phase has particles within nanometer
range. Nanocapsules and nanospheres formulations are
characterized by EM techniques. Quantitative characterization has become much easier and reproducible by
laser beam analyses, which might be a technique of
choice for scientists working in this area.
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